Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma

Abstract Vitreoretinal large B-cell lymphoma (VR-LBCL) is a rare hematologic malignancy. It is classified as primary (PVR-LBCL) or secondary (SVR-LBCL) based on the initial site of manifestation. Owing to limited prospective data and absent standardized guidelines, treatment remains challenging. Thi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sina A. Beer, Carola Huber, Emil Nasyrov, Lasse Wolfram, Martin Pietzsch, Aileen Schenk, Michael Sommer, Andreas Wedrich, Claudia Lengerke, Deshka Doycheva, Christoph Deuter, Daniela Süsskind, Stefan Wirths, David A. Merle
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2026-02-01
coleção:	Scientific Reports
Assuntos:	Vitreoretinal lymphoma Orphan disease Relapse-free survival PVRL PIOL
Acesso em linha:	https://doi.org/10.1038/s41598-026-37804-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!